Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Goldman's new investment list includes Apple, Amazon, JPMorgan

Published 01/06/2023, 10:54
© Reuters.
JPM
-
MRK
-
VRTX
-
WBD
-
AAPL
-
AMZN
-
CRM
-
HCA
-
WW
-

Goldman Sachs analysts published today a new investment list that consists of 22 stocks highlighted by the broker's research analysts. It includes fundamental Buy-rated U.S. stocks chosen by Goldman's "Investment Review Committee."

"This new "Conviction List – Directors' Cut" is designed to provide investors with a curated and active list of 20-25 of what we believe to be our most differentiated fundamental Buy ideas across our US stock coverage," Kron said in a client note.

The list includes mega-cap names like Apple (NASDAQ:AAPL) and Amazon (NASDAQ:AMZN). These two tech stocks offer 18% and 37% upside, respectively, based on Goldman Sachs' price targets.

Other stocks included in the list with a market capitalization exceeding $50 billion include Salesforce (NYSE:CRM), Vertex Pharma (NASDAQ:VRTX), Merck (NYSE:MRK), HCA Healthcare (NYSE:HCA), and JPMorgan Chase (NYSE:JPM).

Stocks with the highest potential are WW International (NASDAQ:WW) and Warner Bros Discovery (NASDAQ:WBD) as analysts see 98% and 86% upside, respectively.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.